Vaccines Manufacturing Technologies

Vaccination is the most important approach to counteract infectious diseases. Thus, the development of new and improved vaccines for existing, emerging, and re-emerging diseases is an area of great interest to the scientific community and the general public. The recent advancements in vaccines defend the folks from the wide range of diseases. The most ability of the vaccines is to induce the body substance protein responses and cell-mediated responses against the big selection of pathogens. To boot, the invention is accustomed to turning out the vaccines, immunogens and valuable therapeutic and diagnostic reagents. Among the tools available for disease prevention and control, vaccines rank high with respect to effectiveness and economic feasibility. Vaccine manufacture is one of the most challenging industries. Manufacturing an anti-virus vaccine today is a complicated process even after the hard task of creating a potential vaccine in the laboratory. There are different vaccine production technologies approved by the U.S. Food and Drug Administration (FDA): egg-based flu vaccine, cell-based flu vaccine, and recombinant flu vaccine• Track 13-1Modular approaches to vaccine production.

  • Vaccines Formulation
  • Cross-flow filtration
  • Increasing vaccine stability
  • Ultracentrifugation operations

Related Conference of Vaccines Manufacturing Technologies

October 25-26, 2019

37thVaccination, Immunization & Antibiotics

Vancouver, Canada
November 12-13, 2019

35th World Vaccines & Immunization Congress

Brisbane, Australia
November 14-15, 2019

2nd International Conference on Vaccine Research

Geneva, Switzerland

Vaccines Manufacturing Technologies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in